$GSK
AI分析生成日 May 11, 2026
AI Score
Hold$GSK
GSK plc
$GSKNYSEHealthcareLarge-Cap
GSK discovers and develops medicines and vaccines in infectious diseases, HIV, oncology, and immunology.
Market Cap
$75.0B
Revenue (TTM)
$37.5B
+5.0%
Net Income (TTM)
$6.0B
+8.0%
EPS (TTM)
$2.90
P/E Ratio
14.0
Dividend Yield
3.5%
52-Week Range
$33-$44
Beta
0.52
Dimension Scores
Fundamental
70Technical
62Sentiment
66Risk / Reward
72Momentum
58Financial Health
Profitability
75moderate
Growth
61moderate
Liquidity
80strong
Solvency
72strong
Efficiency
68strong
Valuation, technical analysis, investment thesis, risk assessment and more for $GSK
Free · No credit card required
免責事項: AI生成の分析は教育目的のみです。投資アドバイスではありません。必ず資格のあるファイナンシャルアドバイザーにご相談ください。